Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Zidovudine and Lamivudine Given Once Versus Twice Daily

This study has been completed.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID) Identifier:
First received: April 7, 2001
Last updated: October 4, 2013
Last verified: October 2013